title: Dose-dependent effects of neonatal SSRI exposure on adult behavior in the rat.
abstract: Neonatal exposure to antidepressants produces lasting impairments in male sexual behavior. Although perturbation of the serotonin system during neonatal life has been implicated in the long-term behavioral effects of neonatal antidepressant exposure, dose-response studies were necessary to confirm that inhibition of the serotonin transporter during the neonatal period is sufficient to produce impairments in sexual behavior. Therefore, the present study examined the dose-response effects of neonatal citalopram exposure on sexual behavior. In addition, the effects of exposure on anxiety-related behavior were examined since alterations in this behavioral measure could affect sexual behavior. Male Long-Evans rats were injected subcutaneously with citalopram (CTM) in one of three doses (5, 10 or 20mg/kg/d), or saline (SAL) in a volume of 0.1 ml twice daily (07:00 and 14:00 h) from PD8 to PD21. The rats were tested as adults (>PD90) for anxiety-like behavior and exploration in the elevated plus maze test and sexual behavior. Neonatal citalopram exposure produced persistent reductions in male sexual behavior characterized by significant dose-dependent reductions in the percentage of male rats displaying mounting as well as dose-dependent reductions in the number of mounts and mount latency. Neonatal citalopram exposure also produced significant dose-dependent linear trends for reductions in intromission and ejaculation behavior. However, neonatal SSRI exposure was not found to produce any effects on exploration or anxiety-like behavior in the elevated plus maze test. The present findings support the hypothesis that inhibition of the serotonin transporter during neonatal life by an SSRI is directly responsible for the long-term effects on male sexual behavior.
authors.affiliation: Department of Pharmacology and Toxicology, University of Mississippi Medical Center Jackson, MS, USA.
authors.forename: Sharonda S
authors.initials: SS
authors.lastname: Harris
authors.forename: Dorota
authors.initials: D
authors.lastname: Maciag
authors.forename: Kimberly L
authors.initials: KL
authors.lastname: Simpson
authors.forename: Rick C S
authors.initials: RC
authors.lastname: Lin
authors.forename: Ian A
authors.initials: IA
authors.lastname: Paul
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D015283:Citalopram / Q000008:administration & dosage / Q000633:toxicity*; D004305:Dose-Response Relationship, Drug; D018782:Maze Learning / Q000187:drug effects; D051381:Rats; D020318:Rats, Long-Evans; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000633:toxicity*; D012726:Sexual Behavior, Animal / Q000187:drug effects*
chemical_list: D015283:Citalopram; D017367:Selective Serotonin Reuptake Inhibitors
references.citation: Pharmacol Biochem Behav. 1996 Jul;54(3):605-9
references.pmid: 8743636
references.citation: Arch Gen Psychiatry. 2006 Aug;63(8):898-906
references.pmid: 16894066
references.citation: Neuropsychopharmacology. 2006 Jan;31(1):47-57
references.pmid: 16012532
references.citation: Brain Res. 1984 Jul;317(1):129-32
references.pmid: 6467028
references.citation: Pharmacol Toxicol. 2002 Jun;90(6):303-10
references.pmid: 12403051
references.citation: Pharmacol Biochem Behav. 1988 Sep;31(1):103-6
references.pmid: 3252240
references.citation: Eur J Pharmacol. 2006 Feb 27;532(3):265-9
references.pmid: 16483567
references.citation: Arq Neuropsiquiatr. 2008 Dec;66(4):844-7
references.pmid: 19099123
references.citation: Arch Pediatr Adolesc Med. 2002 Nov;156(11):1129-32
references.pmid: 12413342
references.citation: Anat Rec (Hoboken). 2010 Nov;293(11):1920-32
references.pmid: 20830689
references.citation: Brain Res. 2003 Nov 21;991(1-2):195-205
references.pmid: 14575892
references.citation: J Sex Med. 2010 Jul;7(7):2435-44
references.pmid: 20497305
references.citation: Lancet. 2005 Feb 5-11;365(9458):482-7
references.pmid: 15705457
references.citation: Basic Clin Pharmacol Toxicol. 2006 Aug;99(2):91-5
references.pmid: 16918708
references.citation: Ann N Y Acad Sci. 1990;600:297-313; discussion 314
references.pmid: 2252317
references.citation: Am J Psychiatry. 2003 May;160(5):993-6
references.pmid: 12727706
references.citation: Neuroscience. 2001;105(1):7-17
references.pmid: 11483296
references.citation: Neurosci Biobehav Rev. 1990 Summer;14(2):217-32
references.pmid: 2190121
references.citation: Brain Res. 2006 Dec 13;1125(1):171-5
references.pmid: 17101120
references.citation: Pharmacol Biochem Behav. 2008 Sep;90(3):416-9
references.pmid: 18457868
references.citation: Neuropsychopharmacology. 2011 Sep;36(10):1961-71
references.pmid: 21525859
references.citation: Neurotoxicology. 1993 Spring;14(1):83-144
references.pmid: 8361683
references.citation: Pharmacol Biochem Behav. 1993 Sep;46(1):215-7
references.pmid: 7902983
references.citation: J Pharmacol Exp Ther. 1997 Dec;283(3):1333-41
references.pmid: 9400008
references.citation: Int J Dev Neurosci. 2005 Feb;23(1):75-83
references.pmid: 15730889
references.citation: Anat Rec. 2002 Jun 1;267(2):87-93
references.pmid: 11997877
references.citation: Br J Pharmacol. 2001 Apr;132(8):1683-90
references.pmid: 11309239
references.citation: Am J Psychiatry. 2002 Nov;159(11):1889-95
references.pmid: 12411224
references.citation: Pharmacol Biochem Behav. 1990 Feb;35(2):327-34
references.pmid: 2320640
references.citation: Horm Behav. 2001 Sep;40(2):291-321
references.pmid: 11534994
references.citation: Brain Res Dev Brain Res. 2001 Jul 23;129(1):107-10
references.pmid: 11454417
references.citation: Arch Gen Psychiatry. 2011 Nov;68(11):1104-12
references.pmid: 21727247
references.citation: Brain Res. 1981 Jan 5;204(1):129-46
references.pmid: 7195762
references.citation: Pediatrics. 2005 Feb;115(2):411-25
references.pmid: 15687451
references.citation: J Neurosci. 2008 Apr 2;28(14):3546-54
references.pmid: 18385313
references.citation: Acta Paediatr. 2001 Mar;90(3):288-91
references.pmid: 11332169
references.citation: Pharmacopsychiatry. 2009 May;42(3):95-100
references.pmid: 19452377
references.citation: Brain Res Bull. 2001 Nov 15;56(5):413-24
references.pmid: 11750787
references.citation: J Pediatr. 2003 Apr;142(4):402-8
references.pmid: 12712058
references.citation: Pharmacol Biochem Behav. 2001 Jul-Aug;69(3-4):325-32
references.pmid: 11509188
references.citation: Neurotoxicol Teratol. 1989 Jan-Feb;11(1):77-84
references.pmid: 2725445
references.citation: Neurosci Biobehav Rev. 1990 Spring;14(1):73-6
references.pmid: 2325943
references.citation: J Neurosci. 2008 Jan 2;28(1):199-207
references.pmid: 18171937
references.citation: Curr Protoc Neurosci. 2004 May;Chapter 8:Unit 8.3
references.pmid: 18428606
references.citation: Arch Gen Psychiatry. 2003 Jul;60(7):720-6
references.pmid: 12860776
references.citation: J Sex Med. 2011 Jan;8(1):97-108
references.pmid: 20704641
references.citation: Psychopharmacology (Berl). 2011 Sep;217(2):211-9
references.pmid: 21499702